A detailed history of Alpine Bank Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Alpine Bank Wealth Management holds 1,366 shares of LLY stock, worth $1.4 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
1,366
Previous 1,088 25.55%
Holding current value
$1.4 Million
Previous $830 Million 76.84%
% of portfolio
0.21%
Previous 0.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 15, 2026

BUY
$799.57 - $1025.28 $222,280 - $285,027
278 Added 25.55%
1,366 $1.47 Billion
Q3 2025

Oct 21, 2025

SELL
$625.65 - $812.69 $31,908 - $41,447
-51 Reduced 4.48%
1,088 $830 Million
Q2 2025

Jul 17, 2025

BUY
$713.71 - $898.95 $32,830 - $41,351
46 Added 4.21%
1,139 $888 Million
Q1 2025

Apr 23, 2025

SELL
$725.72 - $929.72 $1.17 Million - $1.51 Million
-1,619 Reduced 59.7%
1,093 $903 Million
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $2.09 Million - $2.6 Million
2,712 New
2,712 $2.4 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Alpine Bank Wealth Management Portfolio

Follow Alpine Bank Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Bank Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Bank Wealth Management with notifications on news.